Letter to the Editor From Min et al: “Low Vitamin D Levels Are Associated With Long COVID Syndrome in COVID-19 Survivors”
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgad325 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Yu Min und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Dear Editor, We read with great interest the study conducted by Filippo et al (1). First, we congratulate them for their excellent and interesting work evaluating the connection between vitamin D levels and the long COVID syndrome. This study provides new insights into clinical management strategies for COVID-19 survivors in the post-COVID-19 pandemic period. The positive findings on a relationship between low vitamin D levels and long COVID syndrome are a further step in research into links between nutrition and infectious diseases. Nevertheless, some points are worth mentioning that might increase the value readers take from the work of Filippo et al. Compelling observational studies have demonstrated positive associations between vitamin D levels and susceptibility to, severity of, and prognosis of COVID-19 infection. Interestingly, however, these correlations were not successfully validated in randomized controlled trials or genome-wide association studies (2-4). The discrepant conclusions have puzzled physicians about the therapeutic value of vitamin D for patients with COVID-19. If we could find robust evidence of a beneficial role of vitamin D supplementation in reducing the complications caused by infectious diseases like COVID-19, it may be valuable for disease treatment and complication prevention when we face the next global epidemic. In their study (1), Filippo et al applied the propensity score matching method to reduce the bias caused by the small sample size and the retrospective nature of the study. However, some improvements could be considered in future studies to enable better generalization of the findings from bench to bed. First, approximately three-quarters of the included patients were overweight or obese, and vitamin D deficiency was observed in 71 cases (71%). Preexisting metabolic disorders might lead to the reverse causal relationship between low vitamin D levels and long COVID-19 syndrome. Second, the study population was recruited in the second half of 2020, when the Alpha variant of SARS-CoV-2 was predominant, whereas Omicron has become the leading variant since 2022. The different biological characteristics of the 2 variants result in varied impacts on human health conditions. In addition, sociopsychological factors such as a history of depression and anxiety, which have been proven to be associated with a higher risk for long COVID-19 syndrome (5), were not well controlled in the study. Thus, the conclusions should be interpreted cautiously and validated further. Nevertheless, we appreciate the efforts of Filippo and colleagues, which provide us with nutrition-related ways to explain the mechanisms of long COVID-19 syndrome. Future preclinical and well-designed randomized controlled trials are warranted to better clarify the associations between vitamin D levels and the pathophysiological features of long COVID syndrome, especially in terms of vaccinated populations and COVID-19 variants. The work was supported by the National Key Research and Development Program of China (2021YFE0206600), and the National Natural Science Foundation of China (82172842 and 81672386). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no competing interests.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
- Department of Head and Neck Oncology, Department of Radiation Oncology, Cancer Center, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
ORCID-Profile: Xingchen Peng
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Min, Y., Wei, X., & Peng, X. (2023). Letter to the Editor From Min et al: “Low Vitamin D Levels Are Associated With Long COVID Syndrome in COVID-19 Survivors”. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad325
Vancouver
Min Y, Wei X, Peng X. Letter to the Editor From Min et al: “Low Vitamin D Levels Are Associated With Long COVID Syndrome in COVID-19 Survivors”. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad325
BibTeX
@article{Min2023,
author = {Min, Yu and Wei, Xiaoyuan and Peng, Xingchen},
title = {Letter to the Editor From Min et al: “Low Vitamin D Levels Are Associated With Long COVID Syndrome in COVID-19 Survivors”},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgad325}
}
EUVIMED